- Home
- GLU vs PSNL Comparison
GLU vs PSNL Comparison
Compare GLU & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLU
- PSNL
- Stock Information
- Founded
- GLU 2004
- PSNL 2011
- Country
- GLU United States
- PSNL United States
- Employees
- GLU N/A
- PSNL N/A
- Industry
- GLU Finance/Investors Services
- PSNL Medical Specialities
- Sector
- GLU Finance
- PSNL Health Care
- Exchange
- GLU Nasdaq
- PSNL Nasdaq
- Market Cap
- GLU 99.4M
- PSNL 576.8M
- IPO Year
- GLU N/A
- PSNL 2019
- Fundamental
- Price
- GLU $17.63
- PSNL $7.32
- Analyst Decision
- GLU
- PSNL Strong Buy
- Analyst Count
- GLU 0
- PSNL 5
- Target Price
- GLU N/A
- PSNL $8.00
- AVG Volume (30 Days)
- GLU 12.4K
- PSNL 1.7M
- Earning Date
- GLU 01-01-0001
- PSNL 08-06-2025
- Dividend Yield
- GLU 8.60%
- PSNL N/A
- EPS Growth
- GLU N/A
- PSNL N/A
- EPS
- GLU 0.62
- PSNL N/A
- Revenue
- GLU N/A
- PSNL $85,694,000.00
- Revenue This Year
- GLU N/A
- PSNL $0.45
- Revenue Next Year
- GLU N/A
- PSNL $25.75
- P/E Ratio
- GLU $22.50
- PSNL N/A
- Revenue Growth
- GLU N/A
- PSNL 15.57
- 52 Week Low
- GLU $11.61
- PSNL $1.19
- 52 Week High
- GLU $15.40
- PSNL $7.79
- Technical
- Relative Strength Index (RSI)
- GLU 71.86
- PSNL 77.17
- Support Level
- GLU $16.98
- PSNL $6.27
- Resistance Level
- GLU $17.35
- PSNL $7.03
- Average True Range (ATR)
- GLU 0.21
- PSNL 0.52
- MACD
- GLU 0.06
- PSNL 0.08
- Stochastic Oscillator
- GLU 93.64
- PSNL 83.65
About GLU Gabelli Global Utility of Beneficial Ownership
Gabelli Global Utility & Income Trust is a non-diversified, closed-end management investment company. The Fund's objective is to seek a consistent level of after-tax total return. It predominantly invests in stocks of companies involved to a substantial extent in providing products, services, or equipment for the generation or distribution of electricity, gas, or water and infrastructure operations, and in equity securities including preferred securities of companies in other industries, in each case in such securities that are expected to pay periodic dividends.
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.